Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Phytohemagglutinin P (PHA-P) is a mitogen that selectively stimulates hematogenous or lymphoid monocytic cells [1].
Description | Phytohemagglutinin P (PHA-P) is a mitogen that selectively stimulates hematogenous or lymphoid monocytic cells [1]. |
In vitro | Phytohemagglutinin-P (10 μg/ml; 24-48 hours) activation of decidual CD8+ T lymphocytes results in elevated production of interferon gamma and interleukin (IL) 8, accompanied by reduced secretion of granulocyte-macrophage colony-stimulating factor (CSF2), IL1B, IL2, IL6, IL10, IL12, and tumor necrosis factor, independent of gestational age [2]. |
In vivo | Phytohemagglutinin-P, administered intraperitoneally at doses of 25 and 50 mg/kg daily for 15 days to male Sprague-Dawley rats, resulted in a reduction of longitudinal bone growth, chondrocyte numbers, cartilage plate thickness, metaphyseal hard tissue mass, calcified cartilage core percentage, and osteoblast count per millimeter of bone surface. Furthermore, PHA-P elevated osteoclast quantity, osteoclastic nuclei labeling, and the average nuclei count per osteoclast [1]. |
Synonyms | PHA-P |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Phytohemagglutinin P PHA-P inhibitor inhibit